Products
Community
Markets
Brokers
More

Markets
Australia
Stocks
Health Technology
Pharmaceuticals: Other
ACW
Ideas

ACTINOGEN MEDICAL LIMITED

No trades

See on Supercharts

Overview Financials News

Ideas

Discussions Technicals Seasonals

ACW trade ideas

Multiple bullish signals on ACW. Big chart gap to fill @6.5 Very positive signals on MACD and DMI . Momentum building nicely Big chart gap to fill at 6,5c offering a 60% gain in shareprice. A lot of consolidation has taken place below 3c in past 5 months removing the surplus overhang of shares from the previous capital raising.

Long

by sandalwoodcap

Finer Market Points: ASX Top 10 Momentum Stocks: 16 Jul 2024 ASX:I88 NYSE:WTM ASX:AL3 XETR:DGR ASX:FBR ASX:ACW AMEX:TTT GETTEX:SKS ASX:3DP ASX:EZZ Momentum leading shares are the market's best performers today. They are the fastest-growing shares on the ASX over the last 90 days. These companies can't get to be leaders without first appearing on our Launch Pad list. The Launch Pad List is published weekly on Fridays. Today's ASX's Top 10 Quarterly Momentum Stocks are: Infinity Minerals (I88) Waratah Minerals Limited (WTM) AML3D Limited (AL3) DGR Global Limited (DGR) FBR Limited (FBR) Actinogen Medical Limited (ACW) Titomic Limited (TTT) SKS Technologies Group Limited (SKS) Pointerra Limited (3DP) EZZ Life Science Holdings Limited (EZZ)

by ch886

Wait & watch From ATH ($0.195c) in June 2021, it retraced to 61.8%fib zone around $0.08c. Since then it has recovered some lost ground making higher lows. $0.11c is strong historical S/R zone but a break & close above that will potentially be bullish

Long

by UnknownUnicorn792892

$ACW 0.028 May be of interest shortly, targets in blue

Long

by nfury8

Shares in ACW are this morning trading up over 200%Shares in ACW are this morning trading up over 200% from their closing price yesterday. The company released an update regarding their Xanamem product. The key points the company focused on in the release were. - Statistically significant results demonstrate cognitive improvement in healthy elderly subjects dosed with 20mg Xanamem daily in the XanaHES dose escalation study - Statistically significant reduction in serum cortisol following treatment with Xanamem 20mg daily -Xanamem 20mg daily continues to exhibit a good safety profile with no serious adverse events observed -Results significantly enhance the Xanamem dataset and help shape Actinogen’s drug development strategy for the treatment of Alzheimer’s disease and other neurological and metabolic diseases associated with cognitive impairment - Company to host a Conference Call on October 1st, 2019 (today) at 10:30am (AEST)

by Sector_Reports

ACW Update On the daily and weekly both charts on the MACD show some south ,movement while I was pasting up the head and shoulders. I will be looking for a good buy in a day or two to jump on the ride north as soon as MACD start to show a change. Looking for Tips and education so feel free to comment.

by tacobell

ACW I've been watching this one for a very little one waiting for some news. - News drop and bull pushed and found some resistance at 5c. - after over a week it looks to me as resistance has thinned out. I think we are on a new upward trend

by tacobell

ACW confirms reversal Following on from the reversal setup a few days ago, ACW has confirmed the reversal with a higher low. Should see continued rise, albeit slowly, driven by improving FA and expectation of trial results and updates.

Long

by Marty386

ACW clear breakout on Volume A very clear breakout on volume for ACW today. Looks like selling has eased off. Should push higher on sustained volume. look for a confirmation in coming days. Good FA behind this one.

Long

by Marty386

ACW possible reversal.ACW has put in the early stages of a reversal. Low rejected on good volume. Next few days will confirm this possible reversal. Good FA and expectation of results mid year should provide a good catalyst. It appears some value is being seen at current share price. Interesting one to follow.

Long

by Marty386

Love in every #TradingView

100M+

Traders and investors use our platform.

Top website in the world when it comes to all things investing.

1.5M+

Mobile reviews with 4.9 average rating. No other fintech apps are more loved.

10M+

Custom scripts and ideas shared by our users.

@christianrodriguezcdr

@forex.alex

@codymagoo

@ryan_kelly_forex_trader

@Tradeciety - Rolf

@sabaisabai_fx

@shabs.fazl

@TradingView

@tradeviewindore

@dehandreh

@mrfrankly__

@neo_inversion

@zeroskiifrmz

@ankushbajaj111

@zuko_carmona

@chatchingpipss

@thechipotlereport

@TradingView

Whatever the trade

Here's why Here's why

Products

Supercharts
Pine Script®
Stock Screener
ETF Screener
Bond Screener
Crypto Coins Screener
CEX Screener
DEX Screener
Stock Heatmap
ETF Heatmap
Crypto Heatmap
Economic Calendar
Earnings Calendar
Sparks
News
TradingView Desktop
Mobile app
CME Group futures
Eurex futures
US stocks bundle

Company

About
Features
Pricing
Social network
Wall of Love
Athletes
Manifesto
Careers
Blog
Security vulnerability
Status page
Terms of use
Disclaimer
Privacy policy
Cookies policy
Media kit
Accessibility statement
Tarot cards for traders
TradingView merch store

Community

Refer a friend
Ideas
Scripts
House rules
Moderators
Pine Wizards
Pine freelancers
Chat

For business

Widgets
Advertising
Charting libraries
Lightweight Charts™
Advanced Charts
Trading Platform
Brokerage integration
Partner program
Education program